pyrrolidine dithiocarbamate has been researched along with Anterior Horn Cell Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahtoniemi, T; Goldsteins, G; Kanninen, K; Keksa-Goldsteine, V; Koistinaho, J; Malm, T; Salminen, A | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Anterior Horn Cell Disease
| Article | Year |
|---|---|
Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis.
Topics: Animals; Animals, Genetically Modified; Antioxidants; Death; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Humans; Motor Neuron Disease; Neuroglia; Pyrrolidines; Rats; Superoxide Dismutase; Survival Rate; Thiocarbamates | 2007 |